The record
Written from the 1 report below. Nothing here is unsourced.
- Johnson & Johnson has received US FDA approval for its Ottava robotic surgical system, clearing it for the American market.
- The system is approved for several general surgery procedures in the upper abdomen and is designed with a smaller operating room footprint than existing systems.
- The approval lets the company enter the growing soft-tissue robotic surgery market, where it aims to challenge Intuitive Surgical's dominance.
What to watch next
- How quickly Ottava gains adoption in US hospitals against Intuitive Surgical's established systems.
- Whether the FDA approves Ottava for additional procedure types beyond upper-abdominal general surgery.
Coverage1
1 report
English national1
All filed from India
Named United States · Intuitive Surgical · FDA · Johnson & Johnson · Ottava
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.